Direkt zum Inhalt
Merck

Topically applied caffeine induces miosis in the ketamine/xylazine anesthetized rat.

Experimental eye research (2014-08-12)
Martin Kronschläger, Zhaohua Yu, Nooshin Talebizadeh, Linda Maren Meyer, Per Söderberg
ZUSAMMENFASSUNG

The aim of the present study was to examine if topically applied caffeine influences pupil size in ketamine/xylazine anesthetized animals. Two experiments were carried out. In the first experiment, caffeine was topically applied to one of the eyes of 10 ketamine/xylazine anesthetized animals, while vehicle only was topically applied to the contralateral eye. In the second experiment, caffeine was topically applied to both eyes in one group of 10 ketamine/xylazine anesthetized rats, while in another group both eyes vehicle only was topically applied to both eyes. In both experiments pupil diameter was measured at 0, 10, 20, 40 and 60 min after topical application. In three of the animals, the pupil was dilated with tropicamide 5 mg/ml at 60 min after the topical application of caffeine and the pupil diameter was measured. The first experiment showed a relative miosis in caffeine treated eyes as compared to the vehicle treated eye, that changed over time. The second experiment in line with the first experiment, also showed that topically applied caffeine causes a relative miosis as compared to vehicle only that changes over time. Eyes treated with caffeine reacted with quick dilatation after tropicamide application. Topical caffeine antagonizes ketamine/xylazine anesthesia induced mydriasis in a time dependent manner.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Koffein, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Koffein, powder, ReagentPlus®
Sigma-Aldrich
Koffein, anhydrous, 99%, FCC, FG
USP
Koffein, United States Pharmacopeia (USP) Reference Standard
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
Supelco
Ketamine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Coffein Schmelzpunktstandard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Koffein -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Koffein, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
USP
Koffein-Schmelzpunkt-Standard, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Koffein, Sigma Reference Standard, vial of 250 mg
Sigma-Aldrich
Xylazin, ≥99%
Sigma-Aldrich
Koffein, meets USP testing specifications, anhydrous
Supelco
Koffein -Lösung, analytical standard, 1.0 mg/mL in methanol
Supelco
Mettler Toledo Calibration Substance ME 18872, Caffeine, traceable to primary standards (LGC)
Sigma-Aldrich
Koffein, anhydrous, tested according to Ph. Eur.
Sigma-Aldrich
Koffein, BioXtra
Koffein für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Koffein, European Pharmacopoeia (EP) Reference Standard
Ketamin -hydrochlorid, European Pharmacopoeia (EP) Reference Standard